Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis

Circulation Research

Volumn 89, Issue 8, 2001, Pages 670-677

  Lowe, Harry C ^a   Fahmy, Roger G ^a   Kavurma, Mary M ^a   Baker, Andrew ^a   Chesterman, Colin N ^a   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Catalytic DNA; Early growth response factor 1; Gene therapy; Stenting; Transcription factors

Indexed keywords

CYCLINE; EARLY GROWTH RESPONSE FACTOR 1; OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE;

EID: 0035851218     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2001.097867     Document Type: Article

References (45)

1. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
3. Pathobiologic responses to stenting
4. Dramatic increase in the use of coronary stents
5. Frontiers in interventional cardiology
6. Histopathology of in-stent restenosis in patients with peripheral artery disease
7. Endovascular brachytherapy in coronary arteries: The Rotterdam experience
8. Inhibition of restenosis with betaemitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)
9. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
10. Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model
11. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors
12. Early growth response factor 1: A pleiotropic mediator of inducible gene expression
13. Egr-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2
14. Acute local release of fibroblast growth factor-2 but not transforming growth factor-β1 following coronary stenting
15. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis
16. A general purpose RNA-cleaving DNA enzyme
17. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth factor injury
18. On finding all suboptimal foldings of an RNA molecule
19. Egr-1-induced endothelial gene expression: A common theme in vascular injury
20. Experimental intracoronary stenting: Comprehensive experience in a porcine model
21. Local drug delivery systems and prevention of restenosis
22. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty
23. Inhibition of neointima formation after experimental coronary artery stenting: A new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost
24. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
25. A microcomputer-based system for semi-automatic analysis of histological sections
26. Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme
27. Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome
28. Saline infusion via local drug delivery Catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model
29. Coronary angioplasty from the perspective of atherosclerotic plaque: Morphologic predictors of immediate success and restenosis
30. Sequence-specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: Inhibition of the coreceptor function by DNA-enzyme
31. Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA
32. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA
33. Target site selection for an RNA-cleaving catalytic DNA
34. Lack of neointimal proliferation after implantation of Sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
35. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation
36. Inducible expression of Egr-1-dependent genes: A paradigm of transcriptional activation in vascular endothelium
37. Experimental models of coronary artery restenosis
38. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: Analysis and recommendations
39. Gene delivery from a DNA controlled-release stent in porcine coronary arteries
40. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury
41. Antisense oligonucleotide against c-myc administered with the Transportos delivery catheter for the prevention of in-stent restenosis: Results of the randomized ITALICS trial
42. Local delivery of ethanol inhibits intimal hyperplasia in pig coronaries after balloon angioplasty
43. Clopidogrel versus ticlopidine after percutaneous stent placement
44. Percutaneous adenoviral gene transfer into porcine coronary arteries: Is catheter-based gene delivery adapted to coronary circulation?